Novel association between heterozygous genotype of single nucleotide polymorphism C218T in drug transporter ABCC1 gene and increased risk of colon cancer

References

1. ↵
   1. Saudi Cancer Registry

   (2017) KSA:Saudi Cancer Registry, Cancer incidence report (2014), (Saudi Arabia) https://nhic.gov.sa/eServices/Documents/2014.pdf, pp 1–82.
2. ↵
   1. Alsanea N,
   2. Abduljabbar AS,
   3. Alhomoud S,
   4. Ashari LH,
   5. Hibbert D,
   6. Bazarbashi S

   (2015) Colorectal cancer in Saudi Arabia:incidence, survival, demographics and implications for national policies. Ann Saudi Med 35:196–202.

   OpenUrl
3. ↵
   1. Zubaidi A,
   2. AlSubaie N,
   3. AlHumaid A,
   4. Shaik S,
   5. AlKhayal K,
   6. AlObeed O

   (2015) Public awareness of colorectal cancer in Saudi Arabia:A survey of 1070 participants in Riyadh. Saudi J Gastroenterol 21:78–83.

   OpenUrl
4. ↵
   1. Panczyk M

   (2014) Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol 20:9775–9827.

   OpenUrlCrossRefPubMed
5. ↵
   1. Wilkens S

   (2015) Structure and mechanism of ABC transporters. F1000Prime Rep 7:14.

   OpenUrl
6. ↵
   1. Mamo G,
   2. Pandi A

   (2017) A review on ATP binding cassette (ABC) transporters. Int J Pharma Res Health Sci 5:1607–1615.

   OpenUrl
7. ↵
   1. Robey RW,
   2. Pluchino KM,
   3. Hall MD,
   4. Fojo AT,
   5. Bates SE,
   6. Gottesman MM

   (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18:452–464.

   OpenUrlCrossRefPubMed
8. ↵
   1. Cole SPC,
   2. Bhardwaj G,
   3. Gerlach JH,
   4. Mackie JE,
   5. Grant CE,
   6. Almquist KC,
   7. et al.

   (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Yin J,
   2. Zhang J

   (2015) Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism:from discovery to clinical application. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36:927–938.

   OpenUrl
10. ↵
    1. Vulsteke C,
    2. Lambrechts D,
    3. Dieudonné A,
    4. Hatse S,
    5. Brouwers B,
    6. van Brussel T,
    7. et al.

    (2013) Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Ann Oncol 24:1513–1525.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Wang H,
    2. Jin G,
    3. Wang H,
    4. Liu G,
    5. Qian J,
    6. Jin L,
    7. et al.

    (2009) Genetic susceptibility of lung cancer associated with common variants in the 30 untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export. Cancer 115:595–607.

    OpenUrlCrossRefPubMed
12. ↵
    1. Yin J,
    2. Huang Q,
    3. Yang Y,
    4. Zhang J,
    5. Zhong M,
    6. Zhou M,
    7. et al.

    (2009) Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population. Pharmacogenet Genomics 19:206–216.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA,
    6. Jemal A

    (2018) Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.

    OpenUrlCrossRefPubMed
14. ↵
    1. Keppler D

    (2011) Multidrug resistance proteins (MRPs, ABCCs):importance for pathophysiology and drug therapy. Handb Exp Pharmacol 201:299–323.

    OpenUrlCrossRefPubMed
15. ↵
    1. Abdul-Ghani R,
    2. Serra V,
    3. Gyorffy B,
    4. Jürchott K,
    5. Solf A,
    6. Dietel M,
    7. et al.

    (2006) The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene, 25:1743–1752.
16. ↵
    1. Pajic M,
    2. Murray J,
    3. Marshall GM,
    4. Cole SP,
    5. Norris MD,
    6. Haber M

    (2011) ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript. Pharmacogenet Genomics 21:270–279.

    OpenUrlCrossRefPubMed
17. ↵
    1. Kunická T,
    2. Václavíková R,
    3. Hlaváč V,
    4. Vrána D,
    5. Pecha V,
    6. Rauš K,
    7. et al.

    (2014) Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer. PLoS One 9:e101740.

    OpenUrl
18. ↵
    1. Padmanabhan S

    1. Zhang W,
    2. Zhou HH,
    3. Liu Z,
    4. He YJ

    (2014) in Handbook of pharmacogenomics and stratified medicine, Pharmacogenomics in China, ed Padmanabhan S (Academic press, London), pp 999–1013.